- Home
- TLSI vs KELYB Comparison
TLSI vs KELYB Comparison
Compare TLSI & KELYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | KELYB |
|---|---|---|
| Founded | 2010 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 274.3M | 321.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSI | KELYB |
|---|---|---|
| Price | $5.43 | $13.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 118.9K | 2.1K |
| Earning Date | 11-13-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 2.31% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $40,207,000.00 | ★ $4,392,800,000.00 |
| Revenue This Year | $55.47 | $0.72 |
| Revenue Next Year | $40.05 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 49.52 | 0.46 |
| 52 Week Low | $3.42 | $8.38 |
| 52 Week High | $7.95 | $15.15 |
Technical Indicators
Market Signals| Indicator | TLSI | KELYB |
|---|---|---|
| Relative Strength Index (RSI) | 38.68 | 62.40 |
| Support Level | $5.24 | $12.00 |
| Resistance Level | $5.87 | $13.98 |
| Average True Range (ATR) | 0.41 | 0.49 |
| MACD | -0.09 | 0.62 |
| Stochastic Oscillator | 18.35 | 82.57 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About KELYB Kelly Services Inc. Class B
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.